BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25509855)

  • 1. [Polymorphism of RGS2 gene: genetic markers of risk for schizophrenia and pharmacogenetic markers of typical neuroleptics efficiency].
    Gareeva AE; Zakirov DF; Valinurov RG; Khusnutdinova EK
    Mol Biol (Mosk); 2013; 47(6):934-41. PubMed ID: 25509855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glutamate receptors genes polymorphism and the risk of paranoid schizophrenia in Russians and tatars from the Republic of Bashkortostan].
    Gareeva AE; Khusnutdinova EK
    Mol Biol (Mosk); 2014; 48(5):771-81. PubMed ID: 25842862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association analysis between functional polymorphism of the rs4606 SNP in the RGS2 gene and antipsychotic-induced Parkinsonism in Japanese patients with schizophrenia: results from the Juntendo University Schizophrenia Projects (JUSP).
    Higa M; Ohnuma T; Maeshima H; Hatano T; Hanzawa R; Shibata N; Sakai Y; Suzuki T; Arai H
    Neurosci Lett; 2010 Jan; 469(1):55-9. PubMed ID: 19931593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3'-untranslated region.
    Greenbaum L; Smith RC; Rigbi A; Strous R; Teltsh O; Kanyas K; Korner M; Lancet D; Ben-Asher E; Lerer B
    Pharmacogenomics J; 2009 Apr; 9(2):103-10. PubMed ID: 18347610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication.
    Greenbaum L; Strous RD; Kanyas K; Merbl Y; Horowitz A; Karni O; Katz E; Kotler M; Olender T; Deshpande SN; Lancet D; Ben-Asher E; Lerer B
    Pharmacogenet Genomics; 2007 Jul; 17(7):519-28. PubMed ID: 17558307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Brain neurotransmitter systems gene Polymorphism: the Search for pharmacogenetic markers of efficacy of haloperidol in Russians and Tatars].
    Gareeva AE; Kinyasheva KO; Galaktionova DY; Sabirov ET; Valinourov RG; Chudinov AV; Zasedatelev AS; Nasedkina TV; Khusnutdinova EK
    Mol Biol (Mosk); 2015; 49(6):959-67. PubMed ID: 26710776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association polymorphic variants of GRIN2B gene with paranoid schizophrenia and response to common neuroleptics in Russians and Tatars from Bashkortostan Republic].
    Gareeva AE; Zakirov DF; Khusnutdinova EK
    Genetika; 2013 Sep; 49(9):1106-13. PubMed ID: 25486778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration in RGS2 expression level is associated with changes in haloperidol induced extrapyramidal features in a mutant mouse model.
    Greenbaum L; Lifschytz T; Zozulinsky P; Broner EC; Slonimsky A; Kohn Y; Lerer B
    Eur Neuropsychopharmacol; 2012 May; 22(5):379-86. PubMed ID: 21982117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
    Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
    J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of RGS2 and RGS5 variants with schizophrenia symptom severity.
    Campbell DB; Lange LA; Skelly T; Lieberman J; Levitt P; Sullivan PF
    Schizophr Res; 2008 Apr; 101(1-3):67-75. PubMed ID: 18262772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of RGS2 gene polymorphisms with panic disorder in Japanese.
    Mouri K; Hishimoto A; Fukutake M; Nishiguchi N; Shirakawa O; Maeda K
    Kobe J Med Sci; 2010 Apr; 55(5):E116-21. PubMed ID: 20847599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of RGS2 gene polymorphisms with suicide and increased RGS2 immunoreactivity in the postmortem brain of suicide victims.
    Cui H; Nishiguchi N; Ivleva E; Yanagi M; Fukutake M; Nushida H; Ueno Y; Kitamura N; Maeda K; Shirakawa O
    Neuropsychopharmacology; 2008 Jun; 33(7):1537-44. PubMed ID: 17728697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia.
    Campbell DB; Ebert PJ; Skelly T; Stroup TS; Lieberman J; Levitt P; Sullivan PF
    Biol Psychiatry; 2008 Jan; 63(1):32-41. PubMed ID: 17588543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of cytochrome P450 genes polymorphisms (CYP1A1 and CYP1A2) with the development of chronic obstructive pulmonary disease in Bashkortostan].
    Korytina GF; Akhmadishina LZ; Kochetova OV; Zagidullin ShZ; Viktorova TV
    Mol Biol (Mosk); 2008; 42(1):32-41. PubMed ID: 18389617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1846G>A polymorphism of CYP2D6 gene and extrapyramidal side effects during antipsychotic therapy among Russians and Tatars: a pilot study.
    Sychev DA; Burashnikova IS; Kazakov RE
    Drug Metab Pers Ther; 2016 Dec; 31(4):205-212. PubMed ID: 27875318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the cytochrome P450 (CYP1A1) gene polymorphism in the ethnic groups of the Republic of Bashkortostan].
    Kochetova OV; Korytina GF; Akhmadishina LZ; Iskhakov GM; Victorova TV
    Genetika; 2008 Dec; 44(12):1677-83. PubMed ID: 19178087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGS2 C1114G polymorphism and body weight gain in hypertensive patients.
    Sartori M; Ceolotto G; Dorigatti F; Mos L; Santonastaso M; Bratti P; Papparella I; Semplicini A; Palatini P;
    Metabolism; 2008 Mar; 57(3):421-7. PubMed ID: 18249218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel missense polymorphism in the regulator of G-protein signaling 10 gene: analysis of association with schizophrenia.
    Hishimoto A; Shirakawa O; Nishiguchi N; Aoyama S; Ono H; Hashimoto T; Maeda K
    Psychiatry Clin Neurosci; 2004 Oct; 58(5):579-81. PubMed ID: 15482592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
    Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Role of Neurotrophins and Neurexins Genes in the Risk of Paranoid Schizophrenia in Russians and Tatars].
    Gareeva AE; Traks T; Koks S; Khusnutdinova EK
    Genetika; 2015 Jul; 51(7):799-811. PubMed ID: 26410934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.